Trademark Overview
On Friday, March 28, 2025, a trademark application was filed for FRONTIER MEDICINES with the United States Patent and Trademark Office. The USPTO has given the FRONTIER MEDICINES trademark a serial number of 99108588. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, March 28, 2025. This trademark is owned by Frontier Medicines Corporation. The FRONTIER MEDICINES trademark is filed in the Pharmaceutical Products category with the following description:
Small molecule pharmaceuticals for the treatment of heart disease, blood pressure, Alzheimer's disease, arthritis, diabetes, obesity, mitochondrial disease, autoimmune diseases, hypertension, inflammatory bowel disease, amyotrophic lateral sclerosis, neurological diseases, allergies and asthma, hepatic disease, pulmonary disease, renal disease, infectious diseases, pain, peripheral neuropathy, inflammatory disease, autoimmune disease, ulcerative colitis, atopic dermatitis, plaque psoriasis, chronic obstructive pulmonary disease, Crohn’s disease, eosinophilic esophagitis, systemic lupus erythematosus, multiple sclerosis, age-related diseases, rare diseases, and pediatric diseases in humans
